Detalles de la búsqueda
1.
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 23(11): 1441-1450, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36228644
2.
The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14.
Haematologica
; 104(4): 710-716, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30409796
3.
Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
Cancer
; 124(7): 1449-1454, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29315500
4.
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.
Haematologica
; 97(7): 1085-91, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22315486
5.
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial.
Clin Lung Cancer
; 18(3): 303-309, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27993482
6.
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
J Clin Oncol
; 33(23): 2523-9, 2015 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26150440
Resultados
1 -
6
de 6
1
Próxima >
>>